Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Cerebrovasc Dis
; 27(5): 509-18, 2009.
Article
in En
| MEDLINE
| ID: mdl-19372653
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Propionates
/
Platelet Aggregation Inhibitors
/
Cardiovascular Diseases
/
Ischemic Attack, Transient
/
Aspirin
/
Stroke
/
Naphthalenes
Type of study:
Clinical_trials
/
Etiology_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cerebrovasc Dis
Journal subject:
ANGIOLOGIA
/
CEREBRO
Year:
2009
Type:
Article
Affiliation country:
France